- CHICAGO : Genetic testing might have helped identify people who would become depressed or suicidal while taking Sanofi-Aventis' weight loss drug Acomplia, which might have helped keep the drug on the market, US researchers said on Thursday.
They said partial results from a study of the drug in which five people committed suicide confirmed that it increased the risk of psychiatric side effects.